- 2025-04-12 18:01Cyclin K degrader 1
- 2025-04-12 18:01PROTAC PARP1 degrader-4
- 2025-04-12 18:01TCMDC-125457 872113-12-7
- 2025-04-12 18:01SARS-CoV-2-IN-6 2725749-22-2
- 2025-04-12 18:015-Fluoro-4'-thio-cytidine
- 2025-04-12 18:00Butylated hydroxytoluene-d21 (2,6-di-tert-butyl-p-cresol-d21) 64502-99-4
- 2025-04-12 18:002′-Deoxy-2′-fluoroadenosine 64183-27-3
- 2025-04-12 18:00Glu(OtBu)-Val-Cit-PAB-OH 2757059-05-3
- 2025-04-12 18:00CVT-313 199986-75-9
- 2025-04-12 18:00BRD7116 329059-55-4
- 2025-04-12 18:00Anticancer agent 198
- 2025-04-12 18:00Rosuvastatin-d3 (ZD 4522 d3) 1133429-16-9
- 2025-04-12 18:00Atrovastatin-PEG3-FITC 1440755-31-6
- 2025-04-12 18:00TCMDC-125431
- 2025-04-12 18:00Tetramethylkaempferol 16692-52-7
- 2025-04-12 18:00SARS-CoV-2-IN-59 (4-(4,5-dihydro-2-imidazolyl)benzonitrile) 850786-33-3
- 2025-04-12 18:005-Fluoro-3'-beta-C-methyluridine
- 2025-04-12 18:00Tubulin polymerization-IN-58
- 2025-04-12 18:00PROTAC PARP/EGFR ligand 1 2661609-57-8
- 2025-04-12 18:002'-Deoxy-2'-fluoro-β-D-arabino-6-azauridine 908129-24-8
